



Other version: https://www.sciencedirect.com/science/article/pii/S0007091220300830
![]() |
Effect of tranexamic acid by baseline risk of death in acute bleeding patients: a meta-analysis of individual patient-level data from 28 333 patients |
|
Authors | ||
Collaboration | ||
Published in | British journal of anaesthesia. 2020, vol. 124, no. 6, p. 676-683 | |
Abstract | Early administration of the antifibrinolytic drug tranexamic acid reduces death from bleeding in trauma and postpartum haemorrhage. We examined how the effectiveness and safety of antifibrinolytic drugs varies by the baseline risk of death as a result of bleeding. | |
Keywords | Acute Disease — Adult — Antifibrinolytic Agents/therapeutic use — Female — Hemorrhage/drug therapy — Humans — Male — Randomized Controlled Trials as Topic — Risk — Tranexamic Acid/therapeutic use — Young Adult | |
Identifiers | PMID: 32199584 | |
Full text |
![]() ![]() ![]() ![]() Other version: https://www.sciencedirect.com/science/article/pii/S0007091220300830 |
|
Structures | ||
Research group | Epidémiologie clinique et biostatistique (115) | |
Citation (ISO format) | AGERON, Francois-Xavier et al. Effect of tranexamic acid by baseline risk of death in acute bleeding patients: a meta-analysis of individual patient-level data from 28 333 patients. In: British Journal of Anaesthesia, 2020, vol. 124, n° 6, p. 676-683. doi: 10.1016/j.bja.2020.01.020 https://archive-ouverte.unige.ch/unige:151584 |